Canadian Medical Assocation

Physicians’ continued concerns about the lack of clinical research, guidance and regulatory oversight for medicinal cannabis prompts CMA to offer members advice on authorizing cannabis for medical purposes and call for unbiased, evidence-based, accredited educational modules and decision-support tools